期刊文献+

替莫唑胺-聚乳酸/羟基乙酸纳米缓释系统对C6胶质瘤细胞凋亡的影响 被引量:1

Effects of temozolomide-PLGA nanometer sustained-release microsphere on apoptosis of glioma C6 cells
下载PDF
导出
摘要 目的观察替莫唑胺(temozolomide,TMZ)-聚乳酸/羟基乙酸(polylactic acid/glycolic acid,PLGA)缓释微球对胶质瘤细胞活性及凋亡的影响。方法将C6胶质瘤细胞样品分为实验组及空白对照组。试验组加入载药量分别为2.5%、5%、7.5%及10%的替莫唑胺-聚乳酸/羟基乙酸缓释微球,空白对照组仅加入PLGA而不加入任何药物。全自动酶标仪检测细胞活性,多参数流式细胞仪分析细胞凋亡率。结果 2.5%、5%、7.5%及10%实验组在第14天时肿瘤细胞凋亡率分别为30.45%±0.24%、35.87%±0.58%、41.56%±0.82%、43.34%±1.24%,与对照组细胞凋亡率(3.02%±0.24%)相比,均能更有效杀灭C6胶质瘤细胞,并且载药量越高效果越强(P<0.05)。使用MTT法检测各组C6胶质瘤细胞的细胞活性,2.5%、5%、7.5%、10%实验组在第3天时细胞活性分别为23.47%±2.65%、14.58%±5.76%、6.24%±7.32%、4.36%±2.41%,与对照组(99.60%)相比,均能更有效抑制肿瘤细胞活性,且载药量越高效果越强(P<0.05),但7.5%组与10%组差异无统计学意义。结论载药量不同的TMZ-PLGA缓释微球均对C6胶质瘤细胞有杀灭作用,一定范围内,载药量越高的缓释微球抑制胶质瘤细胞活性的作用越强。 Objective To observe the effect of temozolomide(TMZ)- polylactic acid/glycolic acid(PLGA) release microspheres(MS) on viability and apoptosis of glioma cell. Methods C6 glioma cell samples were divided into experimental group and control group. TMZ- PLGA release microspheres was added into experimental group with the drug loading of 2.5%, 5%, 7.5% and 10%, and only PLGA was added into blank control group. Cell activity was detected with automatic microplate reader and cell apoptosis rate was analyzed with multi-parameter flow cytometry. Results The apoptosis rate of tumor cell in experimental group with drug loading of 2.5%, 5%, 7.5% and 10% on day 14 were 30.45%±0.24%, 35.87%±0.58%, 41.56%±0.82%, 43.34%±1.24%, respectively. Compared with apoptosis rate in control group(3.02%±0.24%), it could kill C6 glioma cells effectively, and the effect enhanced with the increasing of drug loading(P〈0.05). The viability of C6 glioma cells detected using MTT was 23.47%±2.65%, 14.58%±5.76%, 6.24%±7.32% and 4.36%±2.41% in experimental group with drug loading of 2.5%, 5%, 7.5% and 10% on day 3, compared with control group(99.60%), the tumor cell activity could be inhibited effectively in experimental groups, and the effect enhanced with the increasing of drug loading(P〈0.05), but there was no significant difference between group of 7.5% and group of 10%. Conclusion The C6 glioma cells can be killed by TMZ-PLGA release microspheres of different degree of drug loading. Within a certain range, the higher the drug loading of release microsphere is, the stronger the effect of inhibiting of glioma cells is.
出处 《解放军医学院学报》 CAS 2016年第2期164-166,170,共4页 Academic Journal of Chinese PLA Medical School
基金 北京市卫生局首都卫生发展科研专项项目基金(2011-5001-08)~~
关键词 替莫唑胺 聚乳酸-羟基乙酸共聚物 纳米缓释 temozolomide poly(lactic-co-glycolic acid) nanometer sustained-release
  • 相关文献

参考文献18

二级参考文献55

  • 1马晓东,郭小明,张纪,周定标,许百男.PLGA-地塞米松缓释剂的合成及脑内局部应用研究[J].中国微侵袭神经外科杂志,2006,11(7):324-326. 被引量:2
  • 2[1]Vogelhuber W,Spruss T,Bernhardt G,et al.Efficacy of BCNU and paclitaxel loaded subcutaneous implants in the interstitial chemotherapy of U-87 MG human glioblastoma xenografts[J].Int J Pharm,2002,238:111. 被引量:1
  • 3[2]Engelhard H H.The role of interstitial BCNUchemotherapy in the treatment of malignant glioma[J].Surg Neurol,2000,53:458. 被引量:1
  • 4[3]Fung LK,Ewend MG,Sills A,Pharmacokinetics of interstitial delivery of carmustine,4-hydroperoxycyclophosphamide,and paclitaxel from a biodegradable polymer implant in the monkey brain[J].Cancer Res,1998,58:672. 被引量:1
  • 5[4]Lee JS,An TK,Chae GS,et al.Evaluation of in vitro and in vivo antitumor activity of BCNU-loaded PLGA wafer against 9L gliosarcoma.Eur J Pharm Biopharm,2005,59:169. 被引量:1
  • 6[5]Bacolod MD,Johnson SP,Ali-Osman F,et al.Mechanisms of resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea in human medulloblastoma and rhabdomyosarcomal[J].Molecular Cancer Therapeutics,2002,1:727. 被引量:1
  • 7[6]Ewend MG,Sampath P,Williams JA,et al.Local delivery of chemotherapy prolongs survival in experimental brain metastases from breast carcinoma[J].Neurosurgery,1998,43:1185. 被引量:1
  • 8[7]Hickman MJ,Samson LD,Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents[J].Proc Natl Acad Sci U S A.1999,96:10764. 被引量:1
  • 9[8]Henry S.Friedman JP,Jennifer A.et al.Phase I trial of carmustine plus O6-Benzylguanine for patients with recurrent or progressive malignant glioma[J].Journal of Clinical Oncology,2000,18:3522. 被引量:1
  • 10[9]Wang CH,Li J,Chee ST,et al:The delivery of BCNU to brain tumors[J].J Contro Rel,1999,61:21. 被引量:1

共引文献59

同被引文献19

  • 1Liang D, Schulder M. The role of intraoperative magnetic resonance imaging in glioma surgery [ J ] . Surg Neurol Int, 2012, 3 ( Suppl 4 ): S320-S327. 被引量:1
  • 2Stupp R, Mason WP, Van den Bent M J, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma [J]. NEngl J Med, 2005, 352 ( 10 ) : 987-996. 被引量:1
  • 3Hau P, Koch D, Hundsberger T, et al. Safety and feasibility of long- term temozolomide treatment in patients with high-grade glioma [ J ] . Neurology, 2007, 68 ( 9 ) : 688-690. 被引量:1
  • 4Khasraw M, Bell D, Wheeler H. Long-term use of temozolomide : could you use temozolomide safely for Life in gliomas? [ J ] . J Clin Neurosci, 2009, 16 ( 6 ) : 854-855. 被引量:1
  • 5Seiz M, Krafft U, Freyschlag CF, et al. Long-term adjuvant administration of temozolomide in patients with glioblastoma multiforme : experience of a single institution [ J ] . J Cancer Res Clin Oncol, 2010, 136 ( 11 ) : 1691-1695. 被引量:1
  • 6Darlix A, Banmann C, Lorgis V, et al. Prolonged administration of adjuvant temozolomidc improves survival in adult patients with glioblastoma [ J ] . Anticancer Res, 2013, 33 ( 8 ) : 3467-3474. 被引量:1
  • 7Mannas JP, Lightner DD, Defrates SR, et at. Long-term treatment with temozolomide in malignant glioma [ J ] . J Clin Neurosci, 2014, 21 ( 1 ) : 121-123. 被引量:1
  • 8Galldiks N, Kracht LW, Burghaus L, et at. Patient-tailored, imaging-guided, tong-term temozolomide chemotherapy in patients with glioblastoma [ J ] . Mol Imaging, 2010, 9 ( 1 ) : 40-46. 被引量:1
  • 9Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study : 5-year analysis of the EORTC-NCIC trial[ J ]. Lancet Oncol, 2009, 10( 5 ): 459-466. 被引量:1
  • 10Chen C, Xu T, Lu Y, et at. The efficacy of temozolomide for recurrent glioblastoma muhiforme [ J ]. Eur J Neurol, 2013, 20 ( 2 ) : 223- 230. 被引量:1

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部